B. Andraka-Christou

发表

An Analysis of Primary Care Clinician Communication About Risk, Benefits, and Goals Related to Chronic Opioid Therapy

Elizabeth C. Danielson, Sarah M. Downs, C. Harle, 2019, MDM policy & practice.

Harm Reduction Policy Support among Students at Two U.S. Universities

Shana Harris, Andriy Koval, Danielle N Atkins, 2022, Substance use & misuse.

Criminal Problem-Solving and Civil Dependency Court Policies regarding Medications for Opioid Use Disorder

Danielle N Atkins, B. Andraka-Christou, M. Clark, 2021, Substance abuse.

Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State Laws

Kathryn E. Bouskill, A. Gordon, B. Stein, 2021, Journal of addiction medicine.

Whose opinion matters about medications for opioid use disorder? A cross-sectional survey of social norms among court staff

Danielle N Atkins, B. Andraka-Christou, Danielle N. Atkins, 2020, Substance abuse.

Designing an “Ideal” Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder

B. Andraka-Christou, Rachel Totaram, Olivia Randall-Kosich, 2020, Qualitative health research.

Client attitudes toward virtual treatment court

Kristin A. Bryant, Tara L. Kunkel, B. Ray, 2022, Journal of Substance Abuse Treatment.

AMERICA NEEDS THE TREAT ACT: EXPANDING ACCESS TO EFFECTIVE MEDICATION FOR TREATING ADDICTION.

B. Andraka-Christou, 2016, Health matrix.

Pain clinic definitions in the medical literature and U.S. state laws: an integrative systematic review and comparison

Brittany L. Brown-Podgorski, R. Silverman, D. Watson, 2018, Substance Abuse Treatment, Prevention, and Policy.

A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder

J. Buche, A. Beck, B. Andraka-Christou, 2020, Substance Abuse Treatment, Prevention, and Policy.

College students’ perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities

Shana Harris, Thuy Nguyen, J. Ford, 2020, The American journal of drug and alcohol abuse.

Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost

Danielle N Atkins, B. Andraka-Christou, Rachel Totaram, 2022, Health & justice.

Trends in visits to substance use disorder treatment facilities in 2020.

Kathryn E. Bouskill, C. Whaley, B. Stein, 2021, Journal of substance abuse treatment.

A national survey of state laws regarding medications for opioid use disorder in problem-solving courts

A. Gordon, B. Stein, B. Saloner, 2022, Health & Justice.

Policy process lessons from the Orphan Drug Act: applications for health policy advocates

B. Andraka-Christou, Barbara Andraka-Christou, 2015 .

Common themes in early state policy responses to substance use disorder treatment during COVID-19

Kathryn E. Bouskill, A. Gordon, B. Stein, 2021, The American journal of drug and alcohol abuse.

Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment

B. Andraka-Christou, Camila L. Arnaudo, Kacy L. Allgood, 2017, Current Addiction Reports.

Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder

K. Simon, W. Bradford, Thuy Nguyen, 2019, JAMA network open.

Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff

B. Andraka-Christou, Danielle N. Atkins, 2020, The American journal of drug and alcohol abuse.

Paper trails, trailing behind: improving informed consent to IVF through multimedia applications.

J. Madeira, B. Andraka-Christou, 2016, Journal of law and the biosciences.

Stigmatization of Medications for Opioid Use Disorder in 12-Step Support Groups and Participant Responses

B. Andraka-Christou, Rachel Totaram, Olivia Randall-Kosich, 2021, Substance abuse.

State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants

B. Stein, B. Andraka-Christou, Jordan M. Harrison, 2022, Medical care research and review : MCRR.

Introduction to the special issue on innovative interventions and approaches to expand medication assisted treatment: Seizing research opportunities made available by the opioid STR program.

D. Watson, B. Andraka-Christou, Thomas Clarke, 2020, Journal of substance abuse treatment.

Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.

B. Andraka-Christou, Rachel Totaram, Olivia Randall-Kosich, 2020, Journal of addiction medicine.

Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder.

T. Pigott, Kennicia Fortson, B. Andraka-Christou, 2022, Drug and alcohol dependence.

Court personnel attitudes towards medication-assisted treatment: A state-wide survey.

R. Silverman, M. Gabriel, J. Madeira, 2019, Journal of substance abuse treatment.

A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices.

B. Andraka-Christou, Matthew J. Capone, Barbara Andraka-Christou, 2018, The International journal on drug policy.

Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.

B. Andraka-Christou, 2021, Health affairs.

Comprehensive analysis of discharge reasons from methadone outpatient treatment programs.

B. Andraka-Christou, Rachel Totaram, Thuy-Duong Nguyen, 2022, The American journal on addictions.

Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder.

K. Simon, Thuy Nguyen, B. Andraka-Christou, 2020, Journal of substance abuse treatment.

Factors That Influence Changes to Existing Chronic Pain Management Plans

Elizabeth C. Danielson, Sarah M. Downs, B. Mamlin, 2020, The Journal of the American Board of Family Medicine.

Analysis of US County Characteristics and Clinicians With Waivers to Prescribe Buprenorphine After Changes in Federal Education Requirements

J. Spetz, K. Simon, B. Andraka-Christou, 2022, JAMA network open.

Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance Restrictions, 2017-21.

K. Simon, B. Andraka-Christou, Thuy-Duong Nguyen, 2023, Health affairs.

Legal Limitations Associated with Microdosing Buprenorphine

N. Mendoza, B. Andraka-Christou, M. Evans, 2023, Substance use & misuse.

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019

A. Gordon, B. Stein, B. Saloner, 2023, Annals of medicine.

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021

B. Ray, P. Huynh, R. Wightman, 2023, Drug and alcohol dependence reports.

Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021

K. Simon, Kao-Ping Chua, B. Andraka-Christou, 2022, JAMA Health Forum.

Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C

A. Gordon, B. Stein, B. Saloner, 2022, The American journal of drug and alcohol abuse.

Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing.

J. Spetz, A. Gordon, B. Stein, 2022, Journal of substance abuse treatment.

The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill

J. Spetz, K. Simon, W. Bradford, 2021, Medical care research and review : MCRR.

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants

J. Buche, Victoria Schoebel, B. Andraka-Christou, 2022, Addiction Science & Clinical Practice.

Opting into the Public List of DATA-Waivered Practitioners: Variations by Specialty, Treatment Capacity, and Practitioner Characteristics

K. Simon, Thuy Nguyen, B. Andraka-Christou, 2021, Journal of addiction medicine.

Provider-directed marketing may increase prescribing of medications for opioid use disorder.

K. Simon, W. Bradford, Thuy Nguyen, 2019, Journal of substance abuse treatment.

A Pressing Need for Pharmacotherapy Development to Treat Drug Addiction: An Editorial from a Legal Perspective.

B. Andraka-Christou, Barbara Andraka-Christou, 2016, International review of neurobiology.

What is "Treatment" for Opioid Addiction in Problem-Solving Courts? A Study of 20 Indiana Drug and Veterans Courts

B. Andraka-Christou, 2017 .

Isomorphic Pressures on Jail Diversion: From Serious Mental Illness to Opioid Use Disorder

D. Watson, Monte D Staton, B. Andraka-Christou, 2021 .

Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staff.

R. Silverman, J. Madeira, B. Andraka-Christou, 2020, Drug and alcohol review.

Systematic identification and categorization of opioid prescribing/dispensing policies in 16 states & Washington D.C.

M. Vaiana, B. Stein, Rosanna Smart, 2022, Pain medicine.

College Student Preferences for Substance Use Disorder Educational Videos: A Qualitative Study

B. Andraka-Christou, Brianna Alex, Jody Lyneé Madeira, 2019, Substance use & misuse.

Key person-centered care domains for residential substance use disorder treatment facilities: former clients’ perspectives

Glenn W. Lambie, O. Mazurenko, Morgan C. Shields, 2023, Substance Abuse Treatment, Prevention, and Policy.

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

A. Gordon, B. Stein, A. Dick, 2023, JAMA health forum.

Clinical perspectives on hospitals’ role in the opioid epidemic

C. Harle, M. Bair, O. Mazurenko, 2020, BMC Health Services Research.

A Systematic Review of State Office-Based Buprenorphine Treatment Laws Effective During 2022: Counseling, Dosage, and Visit Frequency Requirements

B. Andraka-Christou, Olivia K. Golan, Adam J. Gordon, 2024, Substance use & addiction journal.

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018

B. Andraka-Christou, Mark Sorbero, Flora Sheng, 2023, Drug and alcohol dependence reports.